Thus, by studying the P2Y2-NLRP3 interaction in early HIV infection, molecular mechanisms underlying NLRP3-mediated bystander CD4 T cell depletion, and HIV neuroinflammation new approaches for the development of HIV vaccine or therapeutic interventions can be well exploited to improve the outcome of the disease. This evidence concerns the gene NLRP3 and HIV infectious disease.